RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

CEO

ISIN

US78349D1072

Listings

0 Comments

Share your thoughts

FAQ

What is RxSight stock price today?▼

The current price of RXST.BOATS is $6.13 USD — it has decreased by -4.22% in the past 24 hours. Watch RxSight stock price performance more closely on the chart.

What is RxSight stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange RxSight stocks are traded under the ticker RXST.BOATS.

What is RxSight market cap?▼

Today RxSight has the market capitalization of 252.96M

When is the next RxSight earnings date?▼

RxSight is going to release the next earnings report on May 12, 2026.

What were RxSight earnings last quarter?▼

RXST.BOATS earnings for the last quarter are -0.22 USD per share, whereas the estimation was -0.33 USD resulting in a +34.27% surprise. The estimated earnings for the next quarter are N/A USD per share.

What is RxSight revenue for the last year?▼

RxSight revenue for the last year amounts to 268.96M USD.

What is RxSight net income for the last year?▼

RXST.BOATS net income for the last year is -77.89M USD.

When did RxSight complete a stock split?▼

RxSight has not had any recent stock splits.